TCMD News | Roxom Stocks

1 BTC

=

- USD

Loading market data...

TC

Mkt Cap

$510.1M

Volume

168.38K

Next Earnings

November 2nd

Chart Financials Earnings News About Insider Filings

Tactile Medical Strengthens Board of Directors with Appointment of Andrea PearsonTactile Systems Technology, Inc. (Nasdaq: TCMD) announced the appointment of Andrea Pearson to its Board of Directors effective March 9, 2026. Pearson is an experienced healthcare executive with over 25 years in the industry, most recently serving as Growth Advisor and Chief Marketing Officer at Harbor Health. She previously held senior roles at DispatchHealth and HealthGrades, where she demonstrated strong track records in scaling businesses and driving revenue growth.GlobeNewswire Inc. · Mar 9, 2026

Stock Market Today: S&P 500, Dow, Nasdaq Futures Jump Ahead Of January FOMC Minutes—Palo Alto Networks, Tactile Systems, DoorDash In Focus (UPDATED)U.S. stock futures rose on Wednesday with the Dow Jones, S&P 500, and Nasdaq 100 all posting gains. Investors await January FOMC minutes and Friday's PCE index release. Key movers include Ovintiv surging 4.17% after announcing a $3 billion asset sale, Tactile Systems jumping 23.53% on strong guidance, Celanese rising 5.94% despite earnings miss, and Palo Alto Networks falling 7.34% after lowering profit guidance.Benzinga · Feb 18, 2026

Tactile Systems Stock Smashes 52-Week High After Strong QuarterTactile Systems Technology (NASDAQ: TCMD) surged 23.35% in premarket trading to a new 52-week high following strong fourth-quarter earnings and the acquisition of LymphaTech. The company reported Q4 EPS of 46 cents (beating consensus of 44 cents) and sales of $103.59 million (up 21%, exceeding estimates of $93.80 million). The $6.8 million acquisition is expected to enhance lymphedema treatment capabilities. For fiscal 2026, the company forecasts sales of $357-$365 million and adjusted EBITDA of $49-$51 million, both above consensus expectations.Benzinga · Feb 18, 2026

Tactile Medical Acquires LymphaTech, Expanding Breadth and Depth of its Lymphedema Solutions PortfolioTactile Systems Technology Inc. (NASDAQ: TCMD) has acquired LymphaTech Inc. for $6.8 million upfront plus potential milestone-based payments. LymphaTech's 3D digital measurement platform for lymphedema assessment will expand Tactile Medical's lymphedema portfolio, enabling more accurate disease identification and progression monitoring. The acquisition positions Tactile Medical as a comprehensive solutions leader for lymphatic dysfunction.Benzinga · Feb 17, 2026

3 Small Caps Drawing Insider and Institutional SupportThe article highlights three small-cap stocks with potential for growth in 2025, focusing on insider and institutional buying amid improving macroeconomic conditions and potential interest rate cuts.Investing.com · Jul 14, 2025

Tactile Medical Launches Next-Generation Nimbl™ Lymphedema PlatformTactile Medical has announced the commercial availability of its next-generation pneumatic compression device, Nimbl, for the treatment of upper extremity lymphedema. Nimbl is significantly smaller, lighter, and more user-friendly than previous devices, and it has received FDA and CMS approvals.GlobeNewswire Inc. · Oct 2, 2024

Compression Therapy Market to Surpass Market Valuation of USD 5.40 Billion by 2031 | SkyQuest TechnologyThe global compression therapy market is expected to reach a valuation of USD 6.26 billion by 2031, growing at a CAGR of 5.40% during the forecast period. The market is driven by the increasing cases of accidents and sports injuries, as well as the growing demand for compression garments and pumps.Benzinga · Sep 16, 2024

Tactile Medical to Release Second Quarter of Fiscal Year 2024 Financial Results on August 5, 2024 - GlobeNewswireTactile Systems Technology, Inc. (Nasdaq: TCMD) announced that it will release its second quarter of fiscal year 2024 financial results on August 5, 2024, and host a conference call to discuss the results.GlobeNewswire Inc. · Jul 22, 2024

Tactile Medical to Present at the William Blair 44th Annual Growth Stock ConferenceMINNEAPOLIS, May 21, 2024 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that management will participate in the William Blair 44th Annual Growth Stock Conference, which is being held at the Loews Hotel in Chicago, IL from June 4th - 6th. Management will participate in a fireside chat on Tuesday, June 4th at 9:20 a.m. Central Time.GlobeNewswire Inc. · May 21, 2024

Are Investors Undervaluing Tactile Systems Technology (TCMD) Right Now?Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.Zacks Investment Research · May 8, 2024

TC

TCMDTactile Systems Technology, Inc.

TCMD

Pay with—

Available Balance0.00

Your PositionYou don't own any TCMD yet.

Related Tickers

Earnings